Moexipril detailed information: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Moexipril detailed information": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
Line 28: | Line 28: | ||
{{CMG}} | {{CMG}} | ||
'''Moexipril''' (marketed under the tradenames '''Univasc''' and '''Perdix''') is an [[ACE inhibitor]]. | '''Moexipril''' (marketed under the tradenames '''Univasc''' and '''Perdix''') is an [[ACE inhibitor]]. | ||
Line 36: | Line 36: | ||
{{ACE inhibitors}} | {{ACE inhibitors}} | ||
[[Category:ACE inhibitors]] | [[Category:ACE inhibitors]] |
Revision as of 17:29, 9 August 2012
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C27H34N2O7 |
Molar mass | 498.568 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Moexipril (marketed under the tradenames Univasc and Perdix) is an ACE inhibitor.
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- ACE inhibitors